Navigation Links
Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
Date:4/22/2008

p> interferon potentiates the activity of combination therapy with

nitazoxanide plus peginterferon. The STEALTH C-1(2) trial used 12

weeks of lead-in therapy with nitazoxanide alone. This clinical study

was designed to evaluate the effect of reducing the lead-in phase from

12 weeks to 4 weeks.

In this Phase II study, 44 patients (40 with HCV genotype 4; 3 with HCV

genotype 1; and 1 with HCV genotype 2) received 4 weeks of nitazoxanide

500 mg twice daily followed by Pegasys(R) (peginterferon alfa-2a) and

nitazoxanide for 36 weeks. Romark's STEALTH C-1 trial (see description

above) was used as an historical control, where randomized patients

were treated for 12 weeks with nitazoxanide before adding SOC treatment.

Analysis of data was by intention to treat.

Thirty-five of 44 patients (80%) treated with a 4-week lead-in phase of

nitazoxanide followed by the addition of peginterferon for 36 weeks

experienced a SVR 12 weeks after the end of treatment (SVR12) compared

to 50% in the SOC historical control group (P = 0.004), 61% in patients

receiving a 12-week lead-in with nitazoxanide followed by 36 weeks of

nitazoxanide plus peginterferon, and 79% in patients receiving a 12-

week lead-in with nitazoxanide followed by 36 weeks of nitazoxanide

plus SOC.

Of the 44 patients in the study, 78% (n=40) of patients with HCV

genotype 4, 100% (n=3) of patients with HCV genotype 1, and 100% (n=1)

of HCV genotype 2, had undetectable virus at 12 weeks following end of

treatment.

Adverse events reported for these 44 patients were similar to those

reported in the STEALTH C-1 trial. Patients treated with nitazoxanide

experienced no more side effects than patients who received the SOC

therapy. Only one of the 44 patients discontinued therapy
'/>"/>

SOURCE Romark Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. Romark Laboratories Raises $18 Million in Institutional Financing
3. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... to the medical, research and veterinary markets, announced today ... Officer, will present at the CL King 12 th ... 9, 2014 at 12:30 p.m. ET. The conference will ... New York City . ...
(Date:8/29/2014)... 29, 2014 Research and Markets  has ... Tissue Repair Devices Market 2014-2018" report to their ... mass of cells that connect, support, or surround bones. ... as tendons, ligaments, cartilage, fascia, and other fibrous tissues. ... tissues with age result in wear and tear in ...
(Date:8/28/2014)...  Rigrodsky & Long, P.A.: , Do you, ... LCI )? , Did you purchase your shares before ... 2014, inclusive? , Did you lose money in your ... to discuss your rights? Rigrodsky & ... Timothy J. MacFall , announces that a complaint has been filed ...
Breaking Medicine Technology:Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3
... Regado Biosciences, a privately held company leading the ... that Ellen McDonald, MBA, Senior Vice President and Chief ... at the Pennsylvania Convention Center in Philadelphia, Pennsylvania.  Ms. ... on Wednesday, November 10 in the Life Science Room ...
... a biopharmaceutical company focused on the discovery and development ... and chronic viral diseases, announced today that it has ... Project (QTDP) administered under section 48D of the Internal ... innovative projects that are determined by the U.S. Department ...
Cached Medicine Technology:Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania 2Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania 3
(Date:8/29/2014)... York, NY (PRWEB) August 29, 2014 ... industry experienced sparse revenue growth over the five ... During the recession, consumers had less disposable income ... grocery stores and visited restaurants less frequently. As ... food establishments declined, hindering revenue growth. “After 2010, ...
(Date:8/29/2014)... 2014 Evolutions Medical & Day Spa ... Santa Barbara News-Press Readers’ Choice 2014 poll. This is ... poll as Best Medical Spa. The 2014 Readers’ Choice ... about Evolutions Medical Spa recognition: , “Not only does ... as a top-notch, cutting-edge medical spa as well. Founder ...
(Date:8/29/2014)... September yoga month was created by ... and its health benefits. To support this Ekhart Yoga ... "Yoga Month Challenge" , This 4 week guided online ... experienced yogis practice yoga regularly from their own home. ... ' is suitable for all levels, and the dynamic ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Senior ... of operations & business development. , Rees has been ... president of business development. , A wholly owned subsidiary ... Independence provides older adults with options, including personalized home ... care (e.g., meal preparation) and therapeutic adult day centers. ...
(Date:8/29/2014)... of Social Work is the recipient of a ... Institute of Drug Abuse (NIDA) at the National Institutes of ... of heroin use. Additionally, the grant provides resources to create ... , Heroin use has increased steadily since 2007 according to ... the cheaper and more available opioid. , A primary ...
Breaking Medicine News(10 mins):Health News:Fruit and Vegetable Wholesaling in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Fruit and Vegetable Wholesaling in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3Health News:Ekhart Yoga Launches the Yoga Month Challenge 2Health News:Senior Independence Promotes Rees to Vice President of Operations & Business Development 2Health News:$1.25 million NIH grant to aid research on impact of heroin use 2
... a prescription that will significantly ease a downsized employee,s healthcare and financial ... ... of 3.6 million jobs since December 2007 - and more than 1.7 ... ill. But the additional loss of healthcare coverage and the unpredictable ...
... supportive of stem cell research funding than consumers ... study conducted among 962 physicians and consumers revealed ... research than consumers after watching President Obama,s speech ... more than half (55%) reported that they agree ...
... mortality rates are down, hospitalisation remains the same , ... Heart Study, which compared acute myocardial infarction (AMI) incidence ... proposed an explanation for the apparent paradox of improved ... The study found that over the past 40 years ...
... March 11 MedCom USA, Inc. (OTC Bulletin ... transaction solutions for the Medical and Dental industries, ... Financial Transaction Portal solutions to AmeriPlan(R) Corporation,s national ... than 200,000 providers in the following fields: dental, ...
... Alliance on Mental Illness (NAMI) Michigan released today the findings ... care in our state. The State of ... in its rating . Fourteen states improved their grades from ... disappointed that Michigan,s mental health care system has deteriorated even ...
... Ron Fink Open Their Door at CareMinders Home Care To ... Their Services.WEST BLOOMFIELD, Mich., March 11 It,s been just ... the lights on in their West Bloomfield offices of CareMinders ... the community.While very few startup companies have been able to ...
Cached Medicine News:Health News:change:healthcare Helps Displaced Employees Immobilized by High Cost of Healthcare 2Health News:change:healthcare Helps Displaced Employees Immobilized by High Cost of Healthcare 3Health News:Docs More Supportive of Stem Cell Research Funding Than Consumers After Viewing President's Speech 2Health News:Docs More Supportive of Stem Cell Research Funding Than Consumers After Viewing President's Speech 3Health News:Explaining trends in heart attack 2Health News:MedCom Signs National Provider Contract With AmeriPlan Corporation 2Health News:MedCom Signs National Provider Contract With AmeriPlan Corporation 3Health News:Michigan's Mental Health Care System Gets a D Grade in Latest Study 2Health News:There is No Place Like CareMinders Home Care and the Dedication and Commitment of the Owners 2
... At Akers, our ultimate goal is ... early detection and immediate treatment. Each year ... suffer and die from late detection or ... lives and cripple nations., ,By developing, manufacturing ...
... BD Macro-Vue RPR (Rapid Plasma Reagin) ... Tests are nontreponemal testing procedures for ... in A Manual of Tests for ... manual are the most widely used ...
Rapid Plasma Reagin (RPR) set is a non-treponemal flocculation test that is,used for the qualitative and semi-quantitative determination of reagin,antibodies in serum or plasma from persons with syph...
... non-reactive quality assurance reagent in assays detecting IgG ... and TOXO IgM), IgG and IgM antibodies to ... and IgM antibodies to cytomegalovirus (CMV IgG and ... simplex virus types 1 and 2 (HSV-1 IgG, ...
Medicine Products: